Study Reveals a New Approach for Alzheimer's Therapies
Berlin, Germany (AFP) – Together with the protein amyloid, the protein medin accumulates in the blood vessels of Alzheimer's sufferers' brains.
"Although medin has been present for more than 20 years, its effects were underestimated," the researchers wrote in the prestigious journal Nature.
"the degenerative alterations in the blood arteries of Alzheimer's patients," said Dr. Jonas Neher, the study's primary investigator and the DZNE's director.
Medin exemplifies amyloid. The most well-known of these proteins is amyloid, which accumulates in the brains of Alzheimer's patients.
Medin, on the other hand, is the most common amyloid and may be found in the blood vessels of nearly everyone over the age of 50.
At the time, it was discovered that medin accumulated more in the mice's brain blood arteries as they aged.
"Only a few research groups worldwide are working on medin," explains Jonas Neher.
They were able to show that these two amyloids co-aggregate, or form mixed deposits, in a later stage.
For More Information And Health Updates Click On Learn More